← Back to Search

Transcranial Magnetic Stimulation for Sensory Learning Studies

N/A
Recruiting
Led By Hannah J Block, PhD
Research Sponsored by Indiana University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Subjects must be between the ages of 18-45 years old and right-handed
Subjects must report being free of Covid symptoms in the week preceding testing
Must not have
Subjects with active malignancy
Subjects with any lymphoproliferative disorder
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1 day
Awards & highlights

Summary

This trial is testing how well different techniques work to improve the accuracy of hand movements in people with damage to the sensorimotor areas of their brain.

Who is the study for?
This trial is for right-handed individuals aged 18-45, free of COVID symptoms and either fully vaccinated or with a recent negative test. Excluded are those with visual/hearing impairments, metal head implants (except titanium), severe hand/arm injuries, drug/alcohol use before testing, sleep deprivation, or certain medical conditions.Check my eligibility
What is being tested?
The study tests how brain stimulation using Theta burst transcranial magnetic stimulation affects sensorimotor learning. It aims to improve understanding of brain regions involved in maintaining accurate hand movements which could enhance rehabilitation for patients with brain lesions.See study design
What are the potential side effects?
Potential side effects may include discomfort at the stimulation site, headache, lightheadedness, or temporary hearing changes due to the noise during the procedure. There's also a small risk of seizure but precautions are taken to minimize this.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am between 18 and 45 years old and right-handed.
Select...
I have not had any COVID-19 symptoms in the past week.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I currently have an active cancer.
Select...
I have a disorder that affects my lymph cells.
Select...
I have had a serious hand or arm injury and haven't fully recovered.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1 day
This trial's timeline: 3 weeks for screening, Varies for treatment, and 1 day for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Realignment
Secondary outcome measures
Motor cortex excitability (arms 1-3)
Tactile sensitivity (arms 1-3)
Target estimation variance
+2 more

Trial Design

7Treatment groups
Experimental Treatment
Placebo Group
Group I: Ventral premotor cortex--Exp 2Experimental Treatment1 Intervention
Theta burst transcranial magnetic stimulation (cTBS) will be applied over Ventral premotor cortex.
Group II: Somatosensory cortex--Exp 1Experimental Treatment1 Intervention
Theta burst transcranial magnetic stimulation (cTBS) will be applied over primary somatosensory cortex.
Group III: Primary motor cortex--Exp 1Experimental Treatment1 Intervention
Theta burst transcranial magnetic stimulation (cTBS) will be applied over primary motor cortex.
Group IV: Cerebellar cortex--Exp 2Experimental Treatment1 Intervention
Theta burst transcranial magnetic stimulation (cTBS) will be applied over cerebellar cortex.
Group V: Anterior superior parietal lobule--Exp 2Experimental Treatment1 Intervention
Theta burst transcranial magnetic stimulation (cTBS) will be applied over Anterior superior parietal lobule.
Group VI: Vertex sham--Exp 1Placebo Group1 Intervention
Sham theta burst transcranial magnetic stimulation (cTBS) will be applied over the vertex.
Group VII: Vertex sham--Exp 2Placebo Group1 Intervention
Sham theta burst transcranial magnetic stimulation (cTBS) will be applied over the vertex.

Find a Location

Who is running the clinical trial?

Indiana UniversityLead Sponsor
997 Previous Clinical Trials
1,095,294 Total Patients Enrolled
3 Trials studying Basic Science
520 Patients Enrolled for Basic Science
National Institute of Neurological Disorders and Stroke (NINDS)NIH
1,349 Previous Clinical Trials
647,877 Total Patients Enrolled
3 Trials studying Basic Science
520 Patients Enrolled for Basic Science
Hannah J Block, PhDPrincipal InvestigatorIndiana University, Bloomington

Media Library

Theta burst transcranial magnetic stimulation Clinical Trial Eligibility Overview. Trial Name: NCT05079516 — N/A
Basic Science Research Study Groups: Somatosensory cortex--Exp 1, Vertex sham--Exp 1, Primary motor cortex--Exp 1, Anterior superior parietal lobule--Exp 2, Ventral premotor cortex--Exp 2, Cerebellar cortex--Exp 2, Vertex sham--Exp 2
Basic Science Clinical Trial 2023: Theta burst transcranial magnetic stimulation Highlights & Side Effects. Trial Name: NCT05079516 — N/A
Theta burst transcranial magnetic stimulation 2023 Treatment Timeline for Medical Study. Trial Name: NCT05079516 — N/A
~32 spots leftby Dec 2024
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top